-
1 . Academic Journal
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial
- 저자
- by Grand'Maison, Francois; Jacques, Francois; Traboulsee, Anthony; Tyblova, Michaela; Meluzinova, Eva, et al.
- 소스
- In The Lancet Neurology September 2021 20(9):729-738